A1 Vertaisarvioitu alkuperäisartikkeli tieteellisessä lehdessä
Rib-sparing scalenotomy in thoracic outlet syndrome treatment: A systematic review and meta-analysis
Tekijät: Ruopsa, Niina; Vastamäki, Heidi; Vahlberg, Tero; Vastamäki, Martti; Ristolainen, Leena
Kustantaja: SAGE PUBLICATIONS LTD
Kustannuspaikka: LONDON
Julkaisuvuosi: 2025
Journal: Scandinavian Journal of Surgery
Tietokannassa oleva lehden nimi: SCANDINAVIAN JOURNAL OF SURGERY
Lehden akronyymi: SCAND J SURG
Vuosikerta: 114
Numero: 2
Aloitussivu: 266
Lopetussivu: 275
Sivujen määrä: 10
ISSN: 1457-4969
eISSN: 1799-7267
DOI: https://doi.org/10.1177/14574969251332910
Verkko-osoite: https://journals.sagepub.com/doi/epub/10.1177/14574969251332910
Rinnakkaistallenteen osoite: https://research.utu.fi/converis/portal/detail/Publication/492317804
Background and Aims: The majority of neurogenic thoracic outlet syndrome (NTOS) surgery still involves removal of the first rib. A rib-sparing procedure has also been found to give a good result, but no meta-analysis has been published about this procedure. Also, from a financial point of view, it is important to know what kind of results have been obtained in the treatment of NTOS with rib-sparing surgery. Our opinion is that first-rib resection (FRR) surgeries, which contain more complications and require a longer recovery time, are performed too often these days, if the same result is achieved with rib-sparing surgery.
Methods: We accomplished a systematic review and meta-analysis to find out the outcome of rib-sparing NTOS surgery, collecting studies on rib-sparing supraclavicular scalenotomy in accordance with the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines using appropriate databases.
Results: Of 1354 studies, 18 studies met our inclusion criteria. The mean study sample size was 58, and the mean patient age at surgery was 35.8 years. All studies reported long-term outcomes, with the mean follow-up time of 49 months. All reported fewer patient complaints after surgical TOS treatment. In our meta-analysis, improvement to Derkash's excellent/good classifications was achieved in 71% (95% confidence interval (CI) = 64.4% to 76.4%, I2 = 73.0%). The heterogeneity noted in the systematic review showed no significant moderation by gender, age, or follow-up time. The studies included had a low risk of publication bias, with most failing to use validated evaluation methods.
Conclusion: According to this analysis, the rib-sparing surgical treatment of NTOS is beneficial to most patients and relatively safe. Still, future studies should accommodate validated thoracic outlet scales
Type of study / level of evidence: Therapeutic IV
Ladattava julkaisu This is an electronic reprint of the original article. |
Julkaisussa olevat rahoitustiedot:
The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The institution of the authors has received, during the study period, funding from Orton EVO grants from the Ministry of Social Affairs and Health, Finland.